NasdaqCM:LLIT

Stock Analysis Report

Executive Summary

Lianluo Smart Limited, through its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in China and internationally.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Lianluo Smart has significant price volatility in the past 3 months.
  • Lianluo Smart is not covered by any analysts.

Similar Companies

Share Price & News

How has Lianluo Smart's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

LLIT

1.2%

US Medical Equipment

-0.6%

US Market


1 Year Return

-57.6%

LLIT

9.7%

US Medical Equipment

0.7%

US Market

LLIT underperformed the Medical Equipment industry which returned 9.9% over the past year.

LLIT underperformed the Market in United States of America which returned 0.7% over the past year.


Share holder returns

LLITIndustryMarket
7 Day0%1.2%-0.6%
30 Day-8.4%3.5%4.9%
90 Day-29.0%3.2%1.7%
1 Year-57.6%-57.6%10.6%9.7%3.0%0.7%
3 Year-56.1%-56.1%70.6%65.4%44.8%35.4%
5 Year-84.8%-84.8%139.4%112.2%62.0%44.3%

Price Volatility Vs. Market

How volatile is Lianluo Smart's share price compared to the market and industry in the last 5 years?


Simply Wall St News

5 months ago | Simply Wall St

How Much Are Lianluo Smart Limited (NASDAQ:LLIT) Insiders Spending On Buying Shares?

Valuation

Is Lianluo Smart undervalued based on future cash flows and its price relative to the stock market?

4.34x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Lianluo Smart to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Lianluo Smart to establish if it is available at substantial discount.


Price Based on Earnings

Lianluo Smart is loss making, we can't compare its value to the US Medical Equipment industry average.

Lianluo Smart is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Lianluo Smart, we can't assess if its growth is good value.


Price Based on Value of Assets

Lianluo Smart is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Lianluo Smart expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lianluo Smart has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Lianluo Smart performed over the past 5 years?

-32.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Lianluo Smart does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Lianluo Smart's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Lianluo Smart's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Lianluo Smart has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Lianluo Smart has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Lianluo Smart improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Lianluo Smart's financial position?


Financial Position Analysis

Lianluo Smart is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Lianluo Smart's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Lianluo Smart has no debt.

Lianluo Smart has no debt compared to 5 years ago when it was 6.6%.


Balance Sheet

High level of physical assets or inventory.

Lianluo Smart has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Lianluo Smart has less than a year of cash runway based on current free cash flow.

Lianluo Smart has less than a year of cash runway if free cash flow continues to grow at historical rates of 34.2% each year.


Next Steps

Dividend

What is Lianluo Smart's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Lianluo Smart's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Lianluo Smart's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Lianluo Smart has not reported any payouts.

Unable to verify if Lianluo Smart's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Lianluo Smart has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Lianluo Smart's salary, the management and board of directors tenure and is there insider trading?

8.2yrs

Average management tenure


CEO

Ping Chen (56yo)

19.7yrs

Tenure

US$31,256

Compensation

Mr. Ping Chen has been the Chief Executive Officer of Lianluo Smart Ltd since 2000 and serves its General Manager and Director since 2003. Mr. Ping served as the Chief Executive Officer of Beijing Chengche ...


CEO Compensation Analysis

Ping's remuneration is lower than average for companies of similar size in United States of America.

Ping's compensation has increased whilst company is loss making.


Management Age and Tenure

8.2yrs

Average Tenure

The average tenure for the Lianluo Smart management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

2.9yrs

Average Tenure

47yo

Average Age

The average tenure for the Lianluo Smart board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Ping Chen (56yo)

    CEO, GM & Director

    • Tenure: 19.7yrs
    • Compensation: US$31.26k
  • Janice Wang

    Chief Technology Officer

    • Tenure: 8.2yrs
  • Lisa Zhou

    Investor Relations Manager

    • Tenure: 0yrs
  • Li Sun

    Vice President and Director of Sales

    • Tenure: 0yrs
  • Fei Dong

    Director of Operations

    • Tenure: 0yrs
  • Yingmei Yang (48yo)

    Interim Chief Financial Officer

    • Tenure: 1.5yrs

Board Members

  • Ping Chen (56yo)

    CEO, GM & Director

    • Tenure: 19.7yrs
    • Compensation: US$31.26k
  • Zhitao He (37yo)

    Chairman

    • Tenure: 2.9yrs
  • Bin Pan (47yo)

    Independent Director

    • Tenure: 2.9yrs
    • Compensation: US$8.00k
  • Richard Chang (56yo)

    Independent Director

    • Tenure: 2.9yrs
    • Compensation: US$8.00k
  • Xiaogang Tong (39yo)

    Independent Director

    • Tenure: 1.1yrs
    • Compensation: US$4.00k

Company Information

Lianluo Smart Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Lianluo Smart Limited
  • Ticker: LLIT
  • Exchange: NasdaqCM
  • Founded: 2003
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$13.533m
  • Shares outstanding: 17.81m
  • Website: https://www.lianluosmart.com

Number of Employees


Location

  • Lianluo Smart Limited
  • China Railway Construction Building
  • 21st Floor
  • Beijing
  • 100040
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LLITNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDApr 2010
J8DDB (Deutsche Boerse AG)YesCommon StockDEEURApr 2010

Biography

Lianluo Smart Limited, through its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in China and internationally. The company offers medical devic ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/23 00:12
End of Day Share Price2019/09/20 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.